SCHEMBL16439261

SCHEMBL16439261

CCCCOc1nccnc1NC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP19A1 P11511 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
GRM5 P41594 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
LMNA P02545 2/20 0.36
STAT3 P40763 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CHRM1 P11229 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14482765 0.79 CYP2D6 (0.38) CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL28897177 0.71 MEN1 (0.44) CYP3A4GRM5SMN1; SMN2NPC1ALDH1A1
SCHEMBL11698190 0.69 CDK1 (0.38) CYP2C9CYP2C19CA12CA1CA2
SCHEMBL21500005 0.69 LMNA (0.46) CA12CA1CA2CA9LMNA
SCHEMBL14482761 0.66 XDH (0.44) CYP2D6CYP3A4CYP2C9CYP2C19CA12
SCHEMBL5712881 0.65 CYP2C19 (0.52) CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19
SCHEMBL9042054 0.65 CHRM1 (0.47) CHRM1
SCHEMBL17269660 0.65 CYP2D6 (0.46) CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19
SCHEMBL7497078 0.64 PDE3B (0.32) GRM5
SCHEMBL31498506 0.64 PDE3B (0.32) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015014836-A1 SUBSTITUTED PYRIDINE-PIPERAZINYL ANALOGUES AS RSV ANTIVIRAL COMPOUNDS JANSSEN R&D IRELAND (IE) 2015-02-05 WO disclosed